[1] |
AKIRA S, UEMATSU S, TAKEUCHI O. Pathogen recognition and innate immunity[J]. Cell, 2006, 124(4):783-801.
|
[2] |
CHEN G, SHAW M H, KIM Y G, et al. NOD-like receptors:role in innate immunity and inflammatory disease[J]. Annu Rev Pathol, 2009, 4:365-398.
|
[3] |
JIN X H, ZHENG L L, SONG M R, et al. A nano silicon adjuvant enhances inactivated transmissible gastroenteritis vaccine through activation the Toll-like receptors and promotes humoral and cellular immune responses[J]. Nanomedicine, 2018, 14(4):1201-1212.
|
[4] |
KUMAR H, KAWAI T, AKIRA S. Pathogen recognition in the innate immune response[J]. Biochem J, 2009, 420(1):1-16.
|
[5] |
PILA E A, TARRABAIN M, KABORE A L, et al. A novel toll-like receptor (TLR) influences compatibility between the gastropod Biomphalaria glabrata, and the digenean trematode Schistosoma mansoni[J]. PLoS Pathog, 2016, 12(3):e1005513.
|
[6] |
CAO Y, SUN Y, CHANG H Y, et al. The E3 ubiquitin ligase RNF 182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation[J]. FEBS Lett, 2019, 593(22):3210-3219.
|
[7] |
SONG Y, LI P S, QIN L P, et al. CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription[J]. Cell Mol Immunol, 2019, doi:10. 1038/s41423-019-0323-0.
|
[8] |
PARK A, RA E A, LEE T A, et al. HCMV-encoded US7 and US8 act as antagonists of innate immunity by distinctively targeting TLR-signaling pathways[J]. Nat Commun, 2019, 10:4670.
|
[9] |
AKIRA S, TAKEDA K. Toll-like receptor signalling[J]. Nat Rev Immunol, 2004, 4(7):499-511.
|
[10] |
BARBALAT R, EWALD S E, MOUCHESS M L, et al. Nucleic acid recognition by the innate immune system[J]. Annu Rev Immunol, 2011, 29:185-214.
|
[11] |
BARTON G M, KAGAN J C. A cell biological view of Toll-like receptor function:regulation through compartmentalization[J]. Nat Rev Immunol, 2009, 9(8):535-542.
|
[12] |
CHAI H C, CHUA K H, LIM S K, et al. Insight into gene polymorphisms involved in toll-like receptor/interferon signalling pathways for systemic lupus erythematosus in South East Asia[J]. J Immunol Res, 2014, 2014:529167.
|
[13] |
DE BOUTEILLER O, MERCK E, HASAN U A, et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH[J]. J Biol Chem, 2005, 280(46):38133-38145.
|
[14] |
KLEINMAN M E, YAMADA K, TAKEDA A, et al. Sequence-and target-independent angiogenesis suppression by siRNA via TLR3[J]. Nature, 2008, 452(7187):591-597.
|
[15] |
SCHULZ O, DIEBOLD S S, CHEN M, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells[J]. Nature, 2005, 433(7028):887-892.
|
[16] |
BARNETT P V, GEALE D W, CLARKE G, et al. A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies I:benefits of higher potency vaccines and associated NSP DIVA test systems in post-outbreak surveillance[J]. Transbound Emerg Dis, 2015, 62(4):367-387.
|
[17] |
JAMAL S M, BELSHAM G J. Foot-and-mouth disease:past, present and future[J]. Vet Res, 2013, 44(1):116.
|
[18] |
KNIGHT-JONES T J D, RUSHTON J. The economic impacts of foot and mouth disease-what are they, how big are they and where do they occur?[J]. Prev Vet Med, 2013, 112(3-4):161-173.
|
[19] |
LI D, LEI C Q, XU Z S, et al. Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway[J]. Sci Rep, 2016, 6:21888.
|
[20] |
WANG D, FANG L R, LI K, et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling[J]. J Virol, 2012, 86(17):9311-9322.
|
[21] |
LI D, YANG W P, YANG F, et al. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway[J]. FASEB J, 2016, 30(5):1757-1766.
|
[22] |
LI M, XIN T, GAO X T, et al. Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-β induction[J]. Biochem Biophys Res Commun, 2018, 504(1):238-244.
|
[23] |
FENG H H, ZHU Z X, CAO W J, et al. Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression[J]. Cell Death Dis, 2018, 9(9):885.
|
[24] |
FU S Z, YANG W P, RU Y, et al. DDX56 cooperates with FMDV 3A to enhance FMDV replication by inhibiting the phosphorylation of IRF3[J]. Cell Signal, 2019, 64:109393.
|
[25] |
何艳春, 杨文萍, 付绍祖, 等. PCBP2促进口蹄疫病毒增殖的机制研究[J]. 畜牧兽医学报, 2018, 49(7):1451-1459.HE Y C, YANG W P, FU S Z, et al. The research on molecular mechanism of PCBP2 promoting the multiplication of foot-and-mouth disease virus[J]. Acta Veterinaria et Zootechnica Sinica, 2018, 49(7):1451-1459. (in Chinese)
|
[26] |
LI D, FU S Z, WU Z Q, et al. DDX56 inhibits type I interferon by disrupting assembly of IRF3-IPO5 to inhibit IRF3 nucleus import[J]. J Cell Sci, 2020, 133(5):jcs230409.
|
[27] |
WANG J Y, ZENG Y, XU S, et al. A naturally occurring deletion in the effector domain of H5N1 swine influenza virus nonstructural protein 1 regulates viral fitness and host innate immunity[J]. J Virol, 2018, 92(11):e00149-18.
|
[28] |
YANG W P, RU Y, REN J J, et al. G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response[J]. Cell Death Dis, 2019, 10(12):946.
|
[29] |
YE W, HU M M, LEI C Q, et al. TRIM8 negatively regulates TLR3/4-mediated innate immune response by blocking TRIF-TBK1 interaction[J]. J Immunol, 2017, 199(5):1856-1864.
|
[30] |
付绍祖, 李露露, 张敬, 等. 猪源DDX56对口蹄疫病毒的复制及其对病毒诱导的RLR通路调节的研究[J]. 畜牧兽医学报, 2019, 50(9):1849-1856.FU S Z, LI L L, ZHANG J, et al. Porcine DDX56 regulates the foot and mouth disease virus replication and the virus-triggered RLR pathway[J]. Acta Veterinaria et Zootechnica Sinica, 2019, 50(9):1849-1856. (in Chinese)
|
[31] |
LI D, YANG W P, REN J J, et al. The E3 ubiquitin ligase TBK1 mediates the degradation of multiple picornavirus VP3 proteins by phosphorylation and ubiquitination[J]. J Virol, 2019, 93(23):e01438-19.
|
[32] |
DOMINGO E, BARANOWSKI E, ESCARMI S C, et al. Foot-and-mouth disease virus[J]. Comp Immunol Microbiol Infect Dis, 2002, 25(5-6):297-308.
|
[33] |
杜平, 尚佑军, 贺延玉, 等. 口蹄疫病毒3D基因的克隆及其编码蛋白的结构和功能预测[J]. 甘肃农业大学学报, 2009, 44(2):20-25.DU P, SHANG Y J, HE Y Y, et al. Cloning of foot-and-mouth disease virus 3D gene and its structure and function[J]. Journal of Gansu Agricultural University, 2009, 44(2):20-25. (in Chinese)
|
[34] |
XUE Q, LIU H S, ZENG Q Y, et al. The DEAD-box RNA helicase DDX1 interacts with the viral protein 3D and inhibits foot-and-mouth disease virus replication[J]. Virol Sin, 2019, 34(6):610-617.
|
[35] |
鲁彬. 口蹄疫病毒3D基因的真核表达及其表达产物的功能分析[J]. 中国兽医科学, 2006, 36(10):800-804.LU B. Eukaryotic expression of foot-and-mouth disease virus 3D gene and functional analysis of the expressed product[J]. Veterinary Science in China, 2006, 36(10):800-804. (in Chinese)
|
[36] |
GARCIÍA-BRIONES M M, BLANCO E, CHIVA C, et al. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D[J]. Virology, 2004, 322(2):264-275.
|
[37] |
SONG X Q, LIU S, WANG W D, et al. E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells[J]. Cell Mol Immunol, 2019, doi:10. 1038/s41423-019-0236-y.
|
[38] |
ZHONG X, FENG L, XU W H, et al. The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding[J]. Cell Mol Immunol, 2019.doi:10. 1038/s41423-019-0265-6.
|
[39] |
ABUJAMRA A L, SPANJAARD R A, AKINSHEYE I, et al. Leukemia virus long terminal repeat activates NFκB pathway by a TLR3-dependent mechanism[J]. Virology, 2006, 345(2):390-403.
|
[40] |
ALEXOPOULOU L, HOLT A C, MEDZHITOV R, et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3[J]. Nature, 2001, 413(6857):732-738.
|
[41] |
HUAI W W, SONG H, YU Z X, et al. Mint3 potentiates TLR3/4-and RIG-I-induced IFN-β expression and antiviral immune responses[J]. Proc Natl Acad Sci U S A, 2016, 113(42):11925-11930.
|